Cost of disorders of the brain in Europe 2010

Research output: Contribution to journalJournal articleResearchpeer-review

  • Anders Gustavsson
  • Mikael Svensson
  • Frank Jacobi
  • Christer Allgulander
  • Jordi Alonso
  • Ettore Beghi
  • Richard Dodel
  • Mattias Ekman
  • Carlo Faravelli
  • Laura Fratiglioni
  • Brenda Gannon
  • David Hilton Jones
  • Jennum, Poul
  • Albena Jordanova
  • Linus Jönsson
  • Korinna Karampampa
  • Martin Knapp
  • Gisela Kobelt
  • Tobias Kurth
  • Roselind Lieb
  • Mattias Linde
  • Christina Ljungcrantz
  • Andreas Maercker
  • Beatrice Melin
  • Massimo Moscarelli
  • Amir Musayev
  • Fiona Norwood
  • Martin Preisig
  • Maura Pugliatti
  • Juergen Rehm
  • Luis Salvador-Carulla
  • Brigitte Schlehofer
  • Roland Simon
  • Hans-Christoph Steinhausen
  • Lars Jacob Stovner
  • Jean-Michel Vallat
  • Peter Van den Bergh
  • Jim van Os
  • Pieter Vos
  • Weili Xu
  • Hans-Ulrich Wittchen
  • Bengt Jönsson
  • Olesen, Jes
  • CDBE2010Study Group
The spectrum of disorders of the brain is large, covering hundreds of disorders that are listed in either the mental or neurological disorder chapters of the established international diagnostic classification systems. These disorders have a high prevalence as well as short- and long-term impairments and disabilities. Therefore they are an emotional, financial and social burden to the patients, their families and their social network. In a 2005 landmark study, we estimated for the first time the annual cost of 12 major groups of disorders of the brain in Europe and gave a conservative estimate of €386 billion for the year 2004. This estimate was limited in scope and conservative due to the lack of sufficiently comprehensive epidemiological and/or economic data on several important diagnostic groups. We are now in a position to substantially improve and revise the 2004 estimates. In the present report we cover 19 major groups of disorders, 7 more than previously, of an increased range of age groups and more cost items. We therefore present much improved cost estimates. Our revised estimates also now include the new EU member states, and hence a population of 514 million people.
Original languageEnglish
JournalEuropean Neuropsychopharmacology
Volume21
Issue number10
Pages (from-to)718-79
Number of pages62
ISSN0924-977X
DOIs
Publication statusPublished - 2011

ID: 40162733